Morgan Stanley’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.34B | Sell |
10,863,528
-1,030,749
| -9% | -$559M | 0.32% | 49 |
|
|
2025
Q4 | $6.89B | Sell |
11,894,277
-827,635
| -7% | -$468M | 0.41% | 33 |
|
|
2025
Q3 | $6.17B | Sell |
12,721,912
-155,683
| -1% | -$72.5M | 0.37% | 38 |
|
|
2025
Q2 | $5.22B | Buy |
12,877,595
+1,282,165
| +11% | +$536M | 0.34% | 43 |
|
|
2025
Q1 | $5.77B | Buy |
11,595,430
+105,141
| +0.9% | +$56.9M | 0.41% | 34 |
|
|
2024
Q4 | $5.98B | Buy |
11,490,289
+348,741
| +3% | +$192M | 0.42% | 33 |
|
|
2024
Q3 | $6.89B | Sell |
11,141,548
-955,965
| -8% | -$566M | 0.5% | 30 |
|
|
2024
Q2 | $6.69B | Buy |
12,097,513
+344,376
| +3% | +$197M | 0.52% | 27 |
|
|
2024
Q1 | $6.83B | Sell |
11,753,137
-13,352,351
| -53% | -$7.49B | 0.55% | 24 |
|
|
2023
Q4 | $13.3B | Buy |
25,105,488
+12,687,059
| +102% | +$6.14B | 0.59% | 23 |
|
|
2023
Q3 | $6.29B | Buy |
12,418,429
+50,736
| +0.4% | +$27M | 0.64% | 22 |
|
|
2023
Q2 | $6.45B | Buy |
12,367,693
+779,148
| +7% | +$420M | 0.64% | 19 |
|
|
2023
Q1 | $6.68B | Sell |
11,588,545
-141,518
| -1% | -$79.8M | 0.72% | 13 |
|
|
2022
Q4 | $6.46B | Buy |
11,730,063
+1,764,312
| +18% | +$935M | 0.73% | 12 |
|
|
2022
Q3 | $5.05B | Buy |
9,965,751
+21,926
| +0.2% | +$12.3M | 0.69% | 13 |
|
|
2022
Q2 | $5.4B | Buy |
9,943,825
+1,627,484
| +20% | +$896M | 0.7% | 13 |
|
|
2022
Q1 | $4.91B | Buy |
8,316,341
+33,984
| +0.4% | +$19.5M | 0.66% | 14 |
|
|
2021
Q4 | $5.53B | Buy |
8,282,357
+172,299
| +2% | +$108M | 0.68% | 16 |
|
|
2021
Q3 | $4.63B | Sell |
8,110,058
-195,995
| -2% | -$108M | 0.62% | 20 |
|
|
2021
Q2 | $4.19B | Buy |
8,306,053
+12,811
| +0.2% | +$6.04M | 0.55% | 28 |
|
|
2021
Q1 | $3.78B | Buy |
8,293,242
+566,814
| +7% | +$271M | 0.56% | 27 |
|
|
2020
Q4 | $3.6B | Buy |
7,726,428
+328,820
| +4% | +$154M | 0.56% | 30 |
|
|
2020
Q3 | $3.27B | Sell |
7,397,608
-265,702
| -3% | -$110M | 0.63% | 28 |
|
|
2020
Q2 | $2.78B | Buy |
7,663,310
+107,355
| +1% | +$36M | 0.61% | 28 |
|
|
2020
Q1 | $2.14B | Sell |
7,555,955
-365,463
| -5% | -$115M | 0.58% | 27 |
|
|
2019
Q4 | $2.57B | Buy |
7,921,418
+1,294,305
| +20% | +$392M | 0.6% | 19 |
|
|
2019
Q3 | $1.93B | Buy |
6,627,113
+2,476,490
| +60% | +$709M | 0.51% | 28 |
|
|
2019
Q2 | $1.22B | Sell |
4,150,623
-38,534
| -0.9% | -$10.6M | 0.32% | 69 |
|
|
2019
Q1 | $1.15B | Sell |
4,189,157
-325,504
| -7% | -$81M | 0.32% | 69 |
|
|
2018
Q4 | $1.01B | Buy |
4,514,661
+27,846
| +0.6% | +$6.53M | 0.3% | 73 |
|
|
2018
Q3 | $1.1B | Buy |
4,486,815
+104,302
| +2% | +$24M | 0.27% | 81 |
|
|
2018
Q2 | $908M | Sell |
4,382,513
-65,884
| -1% | -$14M | 0.25% | 89 |
|
|
2018
Q1 | $918M | Buy |
4,448,397
+4,313
| +0.1% | +$905K | 0.25% | 81 |
|
|
2017
Q4 | $844M | Buy |
4,444,084
+188,728
| +4% | +$36.2M | 0.23% | 84 |
|
|
2017
Q3 | $805M | Sell |
4,255,356
-280,124
| -6% | -$50.7M | 0.24% | 86 |
|
|
2017
Q2 | $791M | Sell |
4,535,480
-129,402
| -3% | -$21.7M | 0.24% | 84 |
|
|
2017
Q1 | $717M | Buy |
4,664,882
+327,826
| +8% | +$50.1M | 0.22% | 94 |
|
|
2016
Q4 | $612M | Sell |
4,337,056
-342,938
| -7% | -$50.6M | 0.2% | 103 |
|
|
2016
Q3 | $744M | Sell |
4,679,994
-316,323
| -6% | -$48.7M | 0.25% | 76 |
|
|
2016
Q2 | $738M | Sell |
4,996,317
-484,082
| -9% | -$71.4M | 0.27% | 81 |
|
|
2016
Q1 | $776M | Sell |
5,480,399
-549,781
| -9% | -$73.7M | 0.3% | 65 |
|
|
2015
Q4 | $855M | Buy |
6,030,180
+286,391
| +5% | +$38.2M | 0.31% | 61 |
|
|
2015
Q3 | $702M | Buy |
5,743,789
+354,876
| +7% | +$46.2M | 0.26% | 75 |
|
|
2015
Q2 | $699M | Buy |
5,388,913
+225,392
| +4% | +$29.4M | 0.24% | 81 |
|
|
2015
Q1 | $694M | Sell |
5,163,521
-237,372
| -4% | -$30.6M | 0.26% | 80 |
|
|
2014
Q4 | $677M | Buy |
5,400,893
+399,760
| +8% | +$48.6M | 0.25% | 85 |
|
|
2014
Q3 | $609M | Buy |
5,001,133
+25,162
| +0.5% | +$3.06M | 0.23% | 89 |
|
|
2014
Q2 | $587M | Sell |
4,975,971
-105,687
| -2% | -$12.4M | 0.23% | 81 |
|
|
2014
Q1 | $611M | Buy |
5,081,658
+73,018
| +1% | +$8.68M | 0.26% | 76 |
|
|
2013
Q4 | $558M | Buy |
5,008,640
+601,160
| +14% | +$59.8M | 0.24% | 82 |
|
|
2013
Q3 | $406M | Sell |
4,407,480
-162,863
| -4% | -$14.7M | 0.19% | 119 |
|
|
2013
Q2 | $387M | Buy |
+4,570,343
| New | +$380M | 0.2% | 119 |
|
Other funds holding TMO
VCM
VPM
Morgan Stanley's TMO Position: Q1 2026 in Review
Morgan Stanley reduced its Thermo Fisher Scientific (TMO) stake by 8.7% in Q1 2026, selling an estimated $559M and leaving 10,863,528 shares worth $5.34B. The position accounts for 0.32% of the portfolio, ranked #49.
Morgan Stanley first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.3B in Q4 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Morgan Stanley held 10,863,528 shares of Thermo Fisher Scientific worth $5.34B as of Q1 2026.
- Morgan Stanley sold 1,030,749 Thermo Fisher Scientific shares in Q1 2026, an estimated $559M.
- Thermo Fisher Scientific made up 0.32% of Morgan Stanley's portfolio in Q1 2026, its #49 holding.
- Morgan Stanley first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Thermo Fisher Scientific position peaked at $13.3B in Q4 2023.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.